Evidence map›Paper›PMID 25977560›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2015

Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

M Waterhouse, H A Risch, C Bosetti, K E Anderson, G M Petersen, W R Bamlet, M Cotterchio, S P Cleary, T I Ibiebele, C La Vecchia and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. A Carabrane-Type Sesquiterpenolide Carabrone fromMolecules (Basel, Switzerland) · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 7 countries.

M WaterhouseDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston Centre for Research Excellence in Sun and Health, Queensland University of Technology, Kelvin Grove, Australia.
H A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, USA.
C BosettiDepartment of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
K E AndersonDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis.
G M PetersenDepartment of Health Sciences Research, Mayo Clinic, Rochester, USA.
W R BamletDepartment of Health Sciences Research, Mayo Clinic, Rochester, USA.
M CotterchioPrevention and Cancer Control, Cancer Care Ontario, Toronto Dalla Lana School of Public Health, University of Toronto, Toronto.
S P ClearyLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto Department of Surgery, University of Toronto, Toronto, Canada.
T I IbiebeleDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston.
C La VecchiaDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
H G SkinnerTruven Health Analytics, Durham.
L StrayerDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis.
P M BracciDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
P MaisonneuveDivision of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
H B Bueno-de-MesquitaNational Institute for Public Health and the Environment, Bilthoven Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.
W Zaton SkiDepartment of Epidemiology, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
L LuDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, USA.
H YuEpidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.
K Janik-KoncewiczDepartment of Epidemiology, The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
J Polesel
D Serraino
R E NealeDivision of Population Health, QIMR Berghofer Medical Research Institute, Herston Centre for Research Excellence in Sun and Health, Queensland University of Technology, Kelvin Grove, Australia rachel.neale@qimrberghofer.edu.au.
Pancreatic Cancer Case–Control Consortium (PanC4)
Mayo Clinic in Florida · USQueensland University of Technology · AUThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Minnesota · USYale University · US3M (United States) · USEuropean Institute of Oncology · ITMario Negri Institute for Pharmacological Research · ITQIMR Berghofer Medical Research Institute · AUTruven Health Analytics (United States) · USUniversity Medical Center Utrecht · NLUniversity of California, San Francisco · USUniversity of Hawaiʻi at Mānoa · USUniversity of Milan · ITUniversity of Toronto · CA

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2004 to 2018
$32.7M
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)R01CA097075 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2002 to 2012
$15.8M
Case-Control Study of Pancreas Cancer Etiologic FactorsR01CA098870 · NCI · YALE UNIVERSITY · PI RISCH, HARVEY A · 2003 to 2008
$3.5M
Molecular Epidemiology of Pancreatic CancerR01CA109767 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRACCI, PAIGE M. · 2005 to 2010
$3.2M
DNA Repair Gene Polymorphysms and Pancreatic CancerR01CA098889 · NCI · DARTMOUTH COLLEGE · PI DUELL, ERIC J · 2003 to 2005
$793k
Pancreas cancer analysis-SF Bay Area case-control studyR03CA108370 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2004 to 2005
$152k
MTHFR POLYMORPHISMS IN PANCREATIC CANCER IN SF BAY AREAR03CA089726 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 2001 to 2002
$148k
PANCREATIC CANCER CASE CONTROL STUDY IN SAN FRANCISCOR01CA059706 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HOLLY, ELIZABETH A. · 1994 to 1998
–
CASE-CONTROL STUDY--PANCREATIC CANCER &AROMATIC AMINESR01CA058697 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ANDERSON, KRISTIN E · 1993 to 1997
–
Canadian Institutes of Health Research MOP-106631NCI NIH HHS 5R01CA098870NCI NIH HHS CA098889NCI NIH HHS CA108370NCI NIH HHS CA109767NCI NIH HHS CA59706NCI NIH HHS CA89726NCI NIH HHS N01-PC-35136NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA102701NCI NIH HHS R01 CA097075NCI NIH HHS R01-CA-58697NCI NIH HHS R01 CA97075
6 · The paper itself

Abstract

backgroundThe potential role of vitamin D in the aetiology of pancreatic cancer is unclear, with recent studies suggesting both positive and negative associations. PATIENTS AND

methodsWe used data from nine case-control studies from the International Pancreatic Cancer Case-Control Consortium (PanC4) to examine associations between pancreatic cancer risk and dietary vitamin D intake. Study-specific odds ratios (ORs) were estimated using multivariable logistic regression, and ORs were then pooled using a random-effects model. From a subset of four studies, we also calculated pooled estimates of association for supplementary and total vitamin D intake.

resultsRisk of pancreatic cancer increased with dietary intake of vitamin D [per 100 international units (IU)/day: OR = 1.13, 95% confidence interval (CI) 1.07-1.19, P = 7.4 × 10(-6), P-heterogeneity = 0.52; ≥230 versus <110 IU/day: OR = 1.31, 95% CI 1.10-1.55, P = 2.4 × 10(-3), P-heterogeneity = 0.81], with the association possibly stronger in people with low retinol/vitamin A intake.

conclusionIncreased risk of pancreatic cancer was observed with higher levels of dietary vitamin D intake. Additional studies are required to determine whether or not our finding has a causal basis.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCase-Control StudiesDiabetes MellitusDietDietary SupplementsFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisObesityOdds RatioVitamin DVitaminscase–control studiespancreatic cancerpooled analysisvitamin D

Identifiers

PMID25977560
PMCPMC4511221
OpenAlexW2167948661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.